FibroTouch<sup>®</sup>对不同BMI水平非酒精性脂肪性肝病患者肝纤维化程度的评估比较

冷雪君; 颜学兵

doi:10.3969/j.issn.1001-5256.2018.09.013

FibroTouch^®对不同BMI水平非酒精性脂肪性肝病患者肝纤维化程度的评估比较

DOI: 10.3969/j.issn.1001-5256.2018.09.013

徐州医科大学附属医院感染性疾病科

基金项目:

国家自然科学基金(81371867)；江苏省医学科技专项-新型临床诊疗技术攻关(2014033)；江苏省“科教兴卫”医学重点人才培养基金(RC2011117)；江苏省研究生科研与实践创新计划项目(SJLX16_0660)；

详细信息

中图分类号: R575.5
计量
- 文章访问数: 747
- HTML全文浏览量: 68
- PDF下载量: 162
- 被引次数: 8
出版历程
- 收稿日期: 2018-03-19
- 出版日期: 2018-09-20

Efficiency of FibroTouch in evaluating liver fibrosis degree in nonalcoholic fatty liver disease patients with different levels of body mass index

Department of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical University

Research funding:

摘要

摘要:
目的观察Fibrotouch无创肝脏硬度测定（LSM）对不同BMI水平的非酒精性脂肪肝病（NAFLD）患者肝纤维化程度的临床评估效能。方法纳入2015年6月-2018年1月徐州医科大学附属医院收治且进行肝穿刺活组织检查的238例NAFLD患者,依据BMI水平分成3组（BMI<24、24≤BMI<28及BMI≥28）,于肝穿刺后1周内进行Fibro Touch检测并于当日空腹进行血样采集,应用计算公式获得各肝纤维化评分指标。分析不同BMI水平组LSM值对肝纤维化程度的评估效能,并分析LSM值与相关血清学肝纤维化指标的相关性,构建受试者工作特征（ROC）曲线,应用曲线下面积（AUC）评价其诊断价值。不同程度肝纤维化NAFLD患者间各项指标的差异采用单因素方差分析及SNK-q法检验;非正态分布资料多个独立样本间比较采用Kruskal-Wallis H检验。LSM值与其他指标的相关性采用Spearman秩相关分析。结果相同BMI水平的NAFLD患者其LSM值在不同肝纤维化程度间差异均有统计学意义（F值分别为18.543、22.985、...
- 非酒精性脂肪性肝病 /
- 肝硬化 /
- 人体质量指数 /
- 诊断
Abstract:
Objective To investigate the efficiency of Fibro Touch noninvasive liver stiffness measurement (LSM) in evaluating liver fibrosis degree in nonalcoholic fatty liver disease (NAFLD) patients with different levels of body mass index (BMI) . Methods A total of 238 NAFLD patients who were admitted to The Affiliated Hospital of Xuzhou Medical University from June 2015 to January 2018 and underwent liver biopsy were enrolled in this study, and according to BMI, they were divided into group A (BMI < 24) , group B (24≤BMI < 28) , and group C (BMI≥28) . Fibro Touch was performed within one week after liver biopsy, and fasting blood samples were collected on the same day. The fibrosis indices were calculated. The efficiency of LSM in evaluating fibrosis degree was analyzed in all groups, and the correlation of LSM with related serological fibrosis indices was analyzed. The receiver operating characteristic (ROC) curve was plotted, and the area under the ROC curve (AUC) was used to evaluate the diagnostic value of LSM and serum markers. A one-way analysis of variance and the SNK-q test were used to investigate the differences in related indices between NAFLD patients with varying fibrosis degrees, and the Kruskal-Wallis H test was used for comparison of non-normally distributed data. The Spearman's rank correlation analysis was used to investigate the correlation between LSM and other indices. Results In group A, B, or C, there was a significant difference in LSM between the NAFLD patients with different fibrosis degrees (F = 18. 543, 22. 985, and 5. 904, P < 0. 001, P < 0. 001, and P = 0. 004) . In the NAFLD patients with progressive liver fibrosis, there was a significant difference in LSM between the patients with different levels of BMI (F = 3. 899, P = 0. 026) . LSM was correlated with Hui score, Forns index, fibrosis-4, and NAFLD fibrosis score (r = 0. 459, 0. 388, 0. 427, and 0. 422, all P < 0. 001) . LSM had the highest efficiency in the diagnosis of progressive liver fibrosis in NAFLD patients, with an AUC of 0. 870, a specificity of 86%, and a sensitivity of 70%. Conclusion Fibro Touch has good value in evaluating the liver fibrosis degree of NAFLD patients, and BMI may affect the result of LSM. LSM is well correlated with other diagnostic indices for liver fibrosis and holds promise for clinical application.
- non-alcoholic fatty liver disease /
- liver cirrhosis /
- body mass index /
- diagnosis

HTML全文

参考文献(21)

[1]LOOMBA R, SANYAL AJ.The global NAFLD epidemic[J].Nat Rev Gastroenterol Hepatol, 2013, 10 (11) :686-690.

[2]ZHU CY, ZHOU D, FAN JG.Advances in diagnosh and treatment of nonalcoholic fatty liver disease[J].Chin J Hepatol, 2016, 24 (2) :81-84. (in Chinese) 朱婵艳, 周达, 范建高.非酒精性脂肪性肝病的诊断与治疗进展[J].中华肝脏病杂志, 2016, 24 (2) :81-84.

[3]YOUNOSSI ZM, STEPANOVA M, NEGRO F, et al.Nonalcoholic fatty liver disease in lean individuals in the United States[J].Medicine, 2012, 91 (6) :319-327.

[4] RINELLA ME.Nonalcoholic fatty liver disease:A systematic review[J].JAMA, 2015, 313 (22) :2263-2273.

[5]OBARA N, UENO Y, FUKUSHIMA K, et al.Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases[J].J Gastroenterol, 2008, 43 (9) :720-728.

[6]YANG EN, CAO WK.Research advances in noninvasive diagnosis of hepatic fibrosis[J].J Clin Hapetol, 2017, 33 (11) :2209-2213. (in Chinese) 杨二娜, 曹武奎.肝纤维化无创诊断的研究进展[J].临床肝胆病杂志, 2017, 33 (11) :2209-2213.

[7]BOURSIER J, VERGNIOL J, GUILLET A, et al.Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by Fibro Scan in non-alcoholic fatty liver disease[J].JHepatol, 2016, 65 (3) :570-578.

[8] CASSINOTTO C, BOURSIER J, de LDINGHEN V, et al.Liver stiffness in nonalcoholic fatty liver disease:A comparison of supersonic shear imaging, Fibro Scan, and ARFI with liver biopsy[J].Hepatology, 2016, 63 (6) :1817-1827.

[9]Group of Fatty Liver and Alcoholic Liver Disease, Society of Hepatology, Chinese Medical Association.Guidelines for management of nonalcoholic fatty liver disease:An update and revised edition[J].Chin J Gastroenterol Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南 (2010年修订版) [J].临床肝胆病杂志, 2010, 26 (2) :120-124.

[10]European Association for the Study of the Liver, Asociación Latinoamericana parael Estudio del Hígado.EASL-ALEH Clinical Practice Guidelines:Non-invasive tests for evaluation of liver disease severity and prognosis[J].J Hepatol, 2015, 63 (1) :237-264.

[11]ZHENG RQ, JIN JY.Advances in the application of ultrasound shear wave elastography in liver diseases[J].Ogran Transplantation, 2017, 8 (4) :260-266. (in Chinese) 郑荣琴, 金洁.超声剪切波弹性成像在肝脏疾病中的应用进展[J].器官移植, 2017, 8 (4) :260-266.

[12]FRAQUELLI M, RIGAMONTI C, CASAZZA G, et al.Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease[J].Gut, 2007, 56 (7) :968-973.

[13]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatits B:A 2015 update[J].J Clin Hapetol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学会分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.

[14]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for hepatits C:A 2015 update[J].J Clin Hapetol, 2015, 31 (12) :1961-1979. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学会分会.丙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1961-1979.

[15]CHALASANI N, YOUNOSSI Z, LAVINE JE, et al.The diagnosis and management of nonalcoholic fatty liver disease:Practice guidance from the American Association for the Study of Liver Diseases[J].Hepatology, 2018, 67 (1) :328-357.

[16]HUI AY, LIEW CT, GO MY, et al.Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B[J].Liver Int, 2004, 24 (6) :611-618.

[17]BRUGUERA M, BARRERA JM, AMPURDANS S, et al.Use of complementary and alternative medicine in patients with chronic hepatitis C[J].Med Clin, 2004, 122 (9) :334-335.

[18]STERLING RK, LISSEN E, CLUMECK N, et al.Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection[J].Hepatology, 2006, 43 (6) :1317-1325.

[19]ANGULO P, HUI JM, MARCHESINI G, et al.The NAFLD fibrosis score:A noninvasive system that identifies hepatic fibrosis in patients with NAFLD[J].Hepatology, 2007, 45 (4) :846-854.

[20]LEI JW, TAN BB, LI WB, et al.Value of transient elastography measured with Fibro Touch in the diagnosis of liver fibrosis in chronic hepatitis patients with hepatocellular carcinoma[J].Chin J Med Offic, 2017, 45 (9) :930-933. (in Chinese) 雷洁雯, 谭碧波, 李万斌, 等.Fibro Touch瞬时弹性成像诊断慢性乙型肝炎合并肝癌患者肝纤维化程度应用研究[J].临床军医杂志, 2017, 45 (9) :930-933.

[21]LIM JK, FLAMM SL, SINGH S, et al.American Gastroenterological Association Institute Guideline on the role of elastography in the evaluation of hepatic fibrosis[J].Gastroenterology, 2017, 152 (6) :1536-1543.

施引文献

期刊类型引用(5)

1.	吕艳杭，吴姗姗，王振常，温智稀，段桂姣，符燕青，农小欣，苏晓文. 柔肝化纤解毒颗粒联合TACE治疗原发性肝癌疗效及对其血清指标和免疫功能的影响. 中华中医药杂志. 2022(04): 2386-2390 . 百度学术
2.	刘雪成，王娟，吴树剑. 增强CT结合血清炎症指标对肝细胞癌病理分级的诊断价值. 齐齐哈尔医学院学报. 2022(18): 1750-1754 . 百度学术
3.	辛健，冯韦韦，何彦丰. 肝脾联合切除术与常规肝切除术治疗肝癌合并脾功能亢进患者肿瘤学效果及风险比较. 中国医师进修杂志. 2021(02): 112-117 . 百度学术
4.	蒲朝煜，王剑杰，周里，陈虹. ~(18)F-FDG PET/CT纳入肝细胞癌肝移植标准的趋势与价值. 临床肝胆病杂志. 2020(02): 421-425 . 本站查看
5.	滕伟峰，毛琦琪，俞丹松，李宏. 消癥益肝片联合mFOLFOX6方案治疗晚期原发性肝癌临床研究. 中华中医药学刊. 2020(04): 204-208 . 百度学术